Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,215 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and efficacy of galantamine in subjects with mild cognitive impairment.
Winblad B, Gauthier S, Scinto L, Feldman H, Wilcock GK, Truyen L, Mayorga AJ, Wang D, Brashear HR, Nye JS; GAL-INT-11/18 Study Group. Winblad B, et al. Neurology. 2008 May 27;70(22):2024-35. doi: 10.1212/01.wnl.0000303815.69777.26. Epub 2008 Mar 5. Neurology. 2008. PMID: 18322263 Clinical Trial.
Amyloid-lowering treatment in Alzheimer's disease.
Jessen F, Frölich L, Hort J, Winblad B, Fortea J. Jessen F, et al. Among authors: winblad b. Lancet. 2024 Nov 30;404(10468):2161-2162. doi: 10.1016/S0140-6736(24)02510-8. Epub 2024 Nov 14. Lancet. 2024. PMID: 39551061 No abstract available.
Point of view: Challenges in implementation of new immunotherapies for Alzheimer's disease.
Aye S, Johansson G, Hock C, Lannfelt L, Sims JR, Blennow K, Frederiksen KS, Graff C, Molinuevo JL, Scheltens P, Palmqvist S, Schöll M, Wimo A, Kivipelto M, Handels R, Frölich L, Zilka N, Tolar M, Johannsen P, Jönsson L, Winblad B. Aye S, et al. Among authors: winblad b. J Prev Alzheimers Dis. 2025 Jan;12(1):100022. doi: 10.1016/j.tjpad.2024.100022. Epub 2025 Jan 1. J Prev Alzheimers Dis. 2025. PMID: 39800469 Free article.
Informal care for people with dementia in Europe.
Handels R, Hataiyusuk S, Wimo A, Sköldunger A, Bakker C, Bieber A, Ciccone A, Defanti CA, Fabbo A, Fascendini S, Frölich L, Gervès-Pinquié C, Gonçalves-Pereira M, Irving K, Koopmans R, Mecocci P, Merlo P, Michalowsky B, Peters O, Pijnenburg Y, Ribeiro Ó, Salbaek G, Schwarzkopf L, Verbeek H, de Vugt M, Woods B, Zanetti O, Winblad B, Jönsson L; Actifcare consortium, ICTUS/DSA group, PLASA/DSA group, RECAGE consortium, RightTimePlaceCare consortium. Handels R, et al. Among authors: winblad b. J Prev Alzheimers Dis. 2025 Jan;12(1):100015. doi: 10.1016/j.tjpad.2024.100015. Epub 2025 Jan 1. J Prev Alzheimers Dis. 2025. PMID: 39800459 Free article.
Post hoc analysis of ADAMANT, a phase 2 clinical trial of active tau immunotherapy with AADvac1 in patients with Alzheimer's disease, positive for plasma p-tau217.
Kovacech B, Cullen NC, Novak P, Hanes J, Kontsekova E, Katina S, Parrak V, Fresser M, Vanbrabant J, Feldman HH, Winblad B, Stoops E, Vanmechelen E, Zilka N. Kovacech B, et al. Among authors: winblad b. Alzheimers Res Ther. 2024 Nov 23;16(1):254. doi: 10.1186/s13195-024-01620-7. Alzheimers Res Ther. 2024. PMID: 39580468 Free PMC article. Clinical Trial.
1,215 results